Skin Cancer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Skin Cancer Treatment Market
The skin cancer treatment market size was valued at USD 8.19 billion in 2019, and the market is now projected to grow from USD 21.08 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2019-2032.
Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the market switched to treating covid patients as priority over the other procedures which led the skin cancer treatment market growth. Additionally, manpower shortages affected manufacturing plants and slowed production due to movement restrictions and lockdowns in several regions. The pandemic has also had a negative impact on facial recognition door lock manufacturing and production facilities. The disruption in the supply chain and the decreased availability of labor, staff, and resources are the causes of this. The market is expected to grow slowly. However, subject to the treatment segment returning to its regular operations, the product demand will gradually revert to its historical estimations as lockdown requirements are gradually relaxed.
According to estimates, rising skin cancer prevalence will support skin cancer treatment market growth during forecast period. The need for skin cancer treatment products is predicted to rise as a result of this incidence increase. Additionally, businesses are concentrating on expanding the use of their cancer medications to include skin cancer. In the upcoming years, the global market for skin cancer treatment is expected to be driven by these recent drug approvals and launches.
Growing use of immunotherapy and targeted therapy medication for skin cancer treatment during forecast period. The growing use of immunotherapy and tailored medications is one of the main market trends for skin cancer treatments. Drugs with targeted therapy also offer improved efficacy in the treatment of skin cancer.
Comprehensive Analysis of Skin Cancer Treatment Market
The skin cancer treatment market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by Disease Indication, by Therapy and by Distribution Channel. The Disease Indication segmentations include Melanoma and Non-Melanoma, By Therapy segmentations include Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy, By Distribution Channel segmentations include Hospital Pharmacy, Retail Pharmacy, and Others.
The North America region lead the skin cancer treatment market by benefitting a market size of USD 3.23 billion in 2019 due to the greater incidence of non-melanoma skin cancer in the Caucasian population, use of immunotherapy and tailored medications and adoption of advanced treatment options.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These prominent key industry players include, Merck & Co., Novartis AG, F. Amgen Inc., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Other prominent players these market players provide a level-playing competitive atmosphere throughout the globe.
In September 2018, The U.S. FDA approved Regeneron Pharmaceuticals, Inc.'s Libtayo to treat metastatic cutaneous squamous cell carcinoma (CSCC) aiming a lot of attraction in the market.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD billion)
SegmentationBy Disease Indication
Melanoma
Non-melanoma
By Therapy
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy
By Distribution Channel
Hospitals Pharmacy
Retail Pharmacy
Others
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Skin Cancer - by Region
- 4.2. Key Mergers, Acquisition, and Partnerships
- 4.3. Pipeline Analysis
- 4.4. New Product Introductions/ Approvals- by Major Players
- 4.5. Overview of Regulatory Scenario - Key Countries
- 5. Global Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Disease Indication
- 5.2.1. Melanoma
- 5.2.2. Non-melanoma
- 5.3. Market Analysis, Insights and Forecast – By Therapy
- 5.3.1. Immunotherapy
- 5.3.2. Targeted Therapy
- 5.3.3. Chemotherapy
- 5.3.4. Radiation Therapy
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Disease Indication
- 6.2.1. Melanoma
- 6.2.2. Non-melanoma
- 6.3. Market Analysis – By Therapy
- 6.3.1. Immunotherapy
- 6.3.2. Targeted Therapy
- 6.3.3. Chemotherapy
- 6.3.4. Radiation Therapy
- 6.4. Market Analysis – By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Others
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Disease Indication
- 7.2.1. Melanoma
- 7.2.2. Non-melanoma
- 7.3. Market Analysis – By Therapy
- 7.3.1. Immunotherapy
- 7.3.2. Targeted Therapy
- 7.3.3. Chemotherapy
- 7.3.4. Radiation Therapy
- 7.4. Market Analysis – By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Others
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Disease Indication
- 8.2.1. Melanoma
- 8.2.2. Non-melanoma
- 8.3. Market Analysis – By Therapy
- 8.3.1. Immunotherapy
- 8.3.2. Targeted Therapy
- 8.3.3. Chemotherapy
- 8.3.4. Radiation Therapy
- 8.4. Market Analysis – By Distribution Channel
- 8.4.1. Hospital Pharmacy
- 8.4.2. Retail Pharmacy
- 8.4.3. Others
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Disease Indication
- 9.2.1. Melanoma
- 9.2.2. Non-melanoma
- 9.3. Market Analysis – By Therapy
- 9.3.1. Immunotherapy
- 9.3.2. Targeted Therapy
- 9.3.3. Chemotherapy
- 9.3.4. Radiation Therapy
- 9.4. Market Analysis – By Distribution Channel
- 9.4.1. Hospital Pharmacy
- 9.4.2. Retail Pharmacy
- 9.4.3. Others
- 9.5. Market Analysis – By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Disease Indication
- 10.2.1. Melanoma
- 10.2.2. Non-melanoma
- 10.3. Market Analysis – By Therapy
- 10.3.1. Immunotherapy
- 10.3.2. Targeted Therapy
- 10.3.3. Chemotherapy
- 10.3.4. Radiation Therapy
- 10.4. Market Analysis – By Distribution Channel
- 10.4.1. Hospital Pharmacy
- 10.4.2. Retail Pharmacy
- 10.4.3. Others
- 10.5. Market Analysis – By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. Merck & Co.
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Bristol Myers Squibb Company
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. F. Hoffmann-La Roche Ltd
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. Amgen Inc.
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. GlaxoSmithKline plc.
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Pfizer Inc.
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Sun Pharmaceutical Industries Ltd.
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Regeneron Pharmaceuticals, Inc.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Other Prominent Players
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook